[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341278-105":59,"doc-detail-341278-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","whole-genome-dna-methylation-profiling-of-intrahepatic-cholangiocarcinoma-reveals-prognostic-subtypes-with-distinct-biological-drivers","Whole-Genome DNA Methylation Profiling of Intrahepatic Cholangiocarcinoma Reveals Prognostic Subtypes with Distinct Biological Drivers","","Intrahepatic cholangiocarcinoma (iCCA) is the second most prevalent primary liver cancer. Whole-genome bisulfite sequencing of 331 iCCA cases combined with genetic, transcriptomic, and proteomic analyses identifies four DNA methylation subtypes (S1–S4) with distinct postoperative outcomes. S2 shows the lowest methylation and highest mutational burden with cell-cycle/DNA replication upregulation; S3 reflects immune heterogeneity and KRAS alteration enrichment; S4 has the best prognosis with near-normal global methylation, FGFR2 fusions/BAP1 mutations, and high copy-number variant burden. Integrative functional work highlights GBP4 demethylation as an epigenetic driver of iCCA proliferation, migration, and invasion.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/whole-genome-dna-methylation-profiling-of-intrahepatic-cholangiocarcinoma-reveals-prognostic-subtypes-with-distinct-biological-drivers/341278/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/whole-genome-dna-methylation-profiling-of-intrahepatic-cholangiocarcinoma-reveals-prognostic-subtypes-with-distinct-biological-drivers/341278.png","ImageObject",300,407,{"name":92,"@type":93},"Violet","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What does whole-genome bisulfite sequencing reveal about iCCA in this study?","Question",{"text":113,"@type":114},"It identifies four iCCA DNA methylation subtypes (S1–S4) that show distinct postoperative clinical outcomes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do the four methylation subtypes differ in biological and clinical features?",{"text":118,"@type":114},"S2 has the lowest methylation and highest mutational burden with cell-cycle/DNA replication upregulation, S3 shows high tumor-immune heterogeneity with carbohydrate-metabolism expression and KRAS alterations, and S4 has near-normal global methylation with FGFR2 fusions/BAP1 mutations and the best prognosis.",{"name":120,"@type":111,"acceptedAnswer":121},"What epigenetic factor is highlighted as an oncogenic driver?",{"text":122,"@type":114},"GBP4 demethylation is identified as a highly prevalent epigenetic oncogenic factor in S2 and S3 that regulates iCCA proliferation, migration, and invasion.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},341278,1790356336,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","Whole-Genome DNA Methylation Proﬁling of Intrahepatic Cholangiocarcinoma Reveals Prognostic Subtypes with Distinct Biological Drivers  \nHaotian Liao1, Xing Chen2, Haichuan Wang1, Youpei Lin3, Lu Chen4, Kefei Yuan1, Mingheng Liao1, Hanyu Jiang5, Jiajie Peng6, Zhenru Wu7, Jiwei Huang1, Jiaxin Li1, and Yong Zeng1  \nABSTRACT  \n◥  \nIntrahepatic cholangiocarcinoma (iCCA) is the second most prevalent primary liver cancer. Although the genetic characterization of iCCA has led to targeted therapies for treating tumors with FGFR2 alterations and IDH1/2 mutations, only a limited number of patients can beneﬁt from these strategies. Epigenomic proﬁles have emerged as potential diagnostic and prognostic biomarkers for improving the treatment of cancers. In this study, we conducted whole-genome bisulﬁte sequencing on 331 iCCAs integrated with genetic, transcriptomic, and proteomic analyses, demonstrating the existence of four DNA methylation subtypes of iCCAs (S1–S4) that exhibited unique postoperative clinical outcomes. The S1 group was an IDH1/2 mutation–speciﬁc subtype with moderate survival. The S2 subtype was characterized by the lowest methylation level and the highest mutational burden among the four subtypes and displayed upregulation of agene-expression pattern associated with cell cycle/DNA replication. The S3 group was distinguished by high interpatient heterogeneity of tumor immunity, a gene-expression pattern  \nassociated with carbohydrate metabolism, and an enrichment ofKRAS alterations. Patients with the S2 and S3 subtypes had the shortest survival among the four subtypes. Tumors in the S4 subtype, which had the best prognosis, showed global methylation levels comparable to normal controls, increased FGFR2 fusions/BAP1 mutations, and the highest copy-number variant burdens. Further integrative and functional analyses identiﬁed GBP4 demethylation, which is highly prevalent in the S2 and S3 groups, as an epigenetic oncogenic factor that regulates iCCA proliferation, migration, and invasion. Together, this study identiﬁes prognostic methylome alterations and epigenetic drivers in iCCA.  \nSigniﬁcance: Characterization of the DNA methylome of intrahepatic cholangiocarcinoma integrated with genomic, transcriptomic, and proteomic analyses uncovers molecular mechanisms affected by genome-wide DNA methylation alterations, providing aresource for identifying potential therapeutic targets.  \n1Division of Liver Surgery, Department of General Surgery and Laboratory of Liver Surgery, and State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China. 2Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China. 3Department of Liver Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, and Key Laboratory of Carcinogenesis and Cancer Invasion,(Ministry of Education), Fudan University, Shanghai, China. 4Department of Hepatobiliary Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China. 5Department of Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. 6School of Computer Science, Northwestern Polytechnical University, Xi’an, Shanxi, China. 7Institute of Clinical Pathology, Key Laboratory of Transplant Engineering and Immunology, NHC, West China Hospital, Sichuan University, Chengdu, Sichuan, China.  \nH. Liao, X. Chen, and H. Wang contributed equally to this article.  \nCorresponding Authors: Yong Zeng, Division of Liver Surgery, Department of General Surgery and Laboratory of Liver Surgery, and State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China. E-mail: [zeng_y@scu.edu.cn](zeng_y@scu.edu.cn); a","cbCaih2qQOPMGdJj","https://ap.wps.com/l/cbCaih2qQOPMGdJj","pdf",15470057,17,"English","# ABSTRACT\n# Introduction","[{\"question\":\"What does whole-genome bisulfite sequencing reveal about iCCA in this study?\",\"answer\":\"It identifies four iCCA DNA methylation subtypes (S1–S4) that show distinct postoperative clinical outcomes.\"},{\"question\":\"How do the four methylation subtypes differ in biological and clinical features?\",\"answer\":\"S2 has the lowest methylation and highest mutational burden with cell-cycle/DNA replication upregulation, S3 shows high tumor-immune heterogeneity with carbohydrate-metabolism expression and KRAS alterations, and S4 has near-normal global methylation with FGFR2 fusions/BAP1 mutations and the best prognosis.\"},{\"question\":\"What epigenetic factor is highlighted as an oncogenic driver?\",\"answer\":\"GBP4 demethylation is identified as a highly prevalent epigenetic oncogenic factor in S2 and S3 that regulates iCCA proliferation, migration, and invasion.\"}]","Whole-Genome DNA Methylation Profiling of Intrahepatic Cholangiocarcinoma Reveals Prognostic Subtypes with Distinct Biological Drivers | PDF",1790041304,43,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6a0b391245a1f5573184718c9bf8f12.webp",983,1286,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/edcf7aff3c403840feeb22b41a24925a.webp",982,1285,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/58c7a9d5b35619094727faffa246750f.webp",981,1283,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14599f01ee078e2cf2ffdc4805c77d2d.webp",980,1282]